National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 17014 [2017-06969]
Download as PDF
17014
Federal Register / Vol. 82, No. 66 / Friday, April 7, 2017 / Notices
nlaroche on DSK30NT082PROD with NOTICES
the provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Council of Councils.
Open: May 26, 2017.
Time: 8:15 a.m. to 11:15 a.m.
Agenda: Call to Order and Introductions;
Announcements and Updates; History of the
Knockout Mouse Program (KOMP); KOMP2
. . . A translational scientific resource to
catalyze biomedical research and accelerate
precision medicine; Background on NIH and
Federal Budget Process; Progress and Plans at
the NIA; Discussion.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Closed: May 26, 2017.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Open: May 26, 2017.
Time: 1:00 p.m. to 3:45 p.m.
Agenda: A study of possible bias
concerning race, gender, seniority and
institution and within the peer review
process; Common Fund Diversity Program—
Introduction and Update and Discussion;
Coming into Focus—The NIH and Health
Research in Tribal Nations; Closing Remarks.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Franziska Grieder, D.V.M.,
Ph.D., Executive Secretary, Director, Office of
Research Infrastructure Programs, Division of
Program Coordination, Planning, and
Strategic Initiatives, Office of the Director,
NIH, 6701 Democracy Boulevard, Room 948,
Bethesda, MD 20892, GriederF@mail.nih.gov,
301–435–0744.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Council of Council’s home page at https://
VerDate Sep<11>2014
14:52 Apr 06, 2017
Jkt 241001
dpcpsi.nih.gov/council/ where an agenda
will be posted before the meeting date.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: April 3, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06906 Filed 4–6–17; 8:45 am]
BILLING CODE 4140–01–P
Time: 1:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Yong Gao, Ph.D., Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, Room
#3G13B, National Institutes of Health/NIAID,
5601 Fishers Lane, MSC 9823, Rockville, MD
20892–7616, (240) 669–5048,
yong.gao@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 3, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06969 Filed 4–6–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: May 1, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Raymond R. Schleef,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3E61, National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
(240) 669–5019, schleefrr@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Rapid Assessment of Zika
Virus (ZIKV) Complications (R21).
Date: May 3–4, 2017.
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
National Institutes of Health
Office of the Secretary: Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Interagency Pain Research Coordinating
Committee (IPRCC).
The meeting will be open to the
public.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Type of meeting: Open Meeting.
Date: May 5, 2017.
Time: 2:00 p.m. to 4:00 p.m. *Eastern
Time*.
Agenda: The meeting will include
discussion of the Federal Pain Research
Strategy and science advances in pain
research.
Place: National Institutes of Health, 31
Center Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Call-In Number: 1–877–668–4493.
Public Access Code: 622 888 818.
Deadline: Submission of intent to submit
written/electronic statement for comments:
Monday, May 1, 2017, by 5:00 p.m. ET.
Contact Person: Linda L. Porter, Ph.D.,
Director, Office of Pain Policy, Officer of the
Director, National Institute of Neurological
Disorders and Stroke, NIH, 31 Center Drive,
Room 8A31, Bethesda, MD 20892, Phone:
(301) 451–4460, Email: Linda.Porter@nih.gov.
Please Note: Any member of the public
interested in submitting written comments to
the Committee must notify the Contact
Person listed on this notice by 5:00 p.m. ET
on Monday, May 1, 2017, with their request.
Interested individuals and representatives of
organizations must submit a written/
E:\FR\FM\07APN1.SGM
07APN1
Agencies
[Federal Register Volume 82, Number 66 (Friday, April 7, 2017)]
[Notices]
[Page 17014]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06969]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: May 1, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Raymond R. Schleef, Ph.D., Senior Scientific
Review Officer, Scientific Review Program, Division of Extramural
Activities, Room 3E61, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5019,
schleefrr@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Rapid Assessment of Zika Virus
(ZIKV) Complications (R21).
Date: May 3-4, 2017.
Time: 1:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Yong Gao, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, Room
#3G13B, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC
9823, Rockville, MD 20892-7616, (240) 669-5048, yong.gao@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: April 3, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-06969 Filed 4-6-17; 8:45 am]
BILLING CODE 4140-01-P